Teknoloji

Total Market Cap 29,626.2B
P/E (Weighted)Price to Earnings ratio. 38.03 Medyan: 36.35
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 5.00
P/E (Arithmetic)Simple average P/E. 44.93
Avg Lothien ScoreFinancial health score (0-100). 50
Avg DamodaranDamodaran scoring model. 43
Avg PotentialExpected upside potential %. -20.3%
Avg Dalio ScoreDalio debt cycle score. 78
Distributions
Lothien Distribution
0–25
1
25–40
8
40–55
17
55–70
14
70–100
1
Damodaran Distribution
0–25
3
25–40
14
40–55
18
55–70
5
70–100
1
Upside Potential
-100% – -20%
25
-20% – +0%
5
+0% – +20%
7
+20% – +50%
3
+50%+
1

Data date 2026-10-19 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-19
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
ADB
217.85 86.9B 13.96 8.40 9.82 52.5% 10.3% 73 74 383.23 +56.9% 84 0.57
LOM
490.20 112.7B 20.43 14.65 14.21 30.9% 9.9% 69 64 567.05 +11.8% 63 2.34
QCI
157.98 167.0B 20.31 6.80 14.75 22.2% 10.3% 67 58 198.37 +19.2% 79 0.55
WDC
317.05 114.5B 14.10 14.79 12.50 54.4% 10.8% 67 54 375.16 +13.7% 93 0.12
NFC
62.06 258.4B 21.53 9.74 8.54 34.9% 10.5% 66 59 84.31 +26.9% 88 0.47
MTE
824.30 931.0B 12.69 10.59 15.34 62.7% 10.7% 66 52 798.57 -2.3% 97 0.06
RRU
15.83 131.1B 19.19 39.29 13.50 528.5% 10.6% 66 58 16.65 +3.9% 84 1.51
FOO
213.95 176.1B 17.75 5.21 14.07 10.5% 9.1% 65 51 286.60 +25.5% 68 1.09
SEJ1
316.00 131.0B 18.25 9.03 10.91 24.9% 10.5% 65 54 359.90 +10.4% 74 0.35
ABEC
304.60 3,725.2B 17.18 6.55 13.01 17.6% 10.5% 64 43 325.95 +5.0% 89 0.18
ORC
116.44 352.1B 21.87 5.94 13.68 11.4% 8.5% 62 54 166.10 +30.7% 59 2.34
639
465.50 95.7B 28.66 11.41 24.79 68.9% 10.8% 59 56 326.57 -22.4% 96 0.06
IBM
209.25 197.1B 20.88 6.50 16.05 12.2% 8.9% 59 49 231.62 +7.2% 56 1.89
FB2A
628.70 1,602.2B 26.49 6.91 16.93 20.8% 10.2% 56 45 519.94 -12.5% 81 0.43
NVD
195.32 4,716.4B 22.50 23.19 22.78 68.9% 10.7% 56 49 132.13 -23.3% 95 0.17
12DA
416.40 266.5B 19.82 — 17.55 56.1% 10.1% 54 53 336.51 -14.4% 69 —
5UR
171.05 230.5B 33.55 3.91 18.04 9.1% 9.9% 54 40 149.55 -9.1% 69 0.59
MSF
477.30 3,545.6B 30.14 9.11 19.15 27.1% 10.7% 54 48 326.91 -22.7% 84 0.13
APC
305.60 4,488.5B 39.20 47.01 30.36 85.5% 10.7% 50 48 164.28 -34.7% 73 0.78
CIS
96.13 379.3B 29.53 8.50 22.45 17.8% 10.4% 50 42 65.92 -23.6% 75 0.59
1YD
302.85 1,445.8B 36.35 16.33 31.78 27.9% 10.5% 49 46 154.71 -36.7% 84 0.60
GCP
279.45 289.9B 36.39 18.51 26.51 30.0% 10.5% 48 49 158.77 -32.4% 75 1.09
TII
244.45 223.2B 41.71 14.02 27.16 23.3% 10.4% 48 44 129.81 -35.2% 80 0.78
ANL
351.75 170.4B 38.14 5.72 28.31 10.8% 10.4% 46 29 203.30 -31.6% 77 0.27
ASME
1,496.40 574.8B 54.03 26.33 43.71 60.2% 10.8% 44 48 671.41 -41.3% 89 0.09
BCO
170.64 120.5B 56.10 22.55 23.59 -8.0% 8.9% 44 30 154.83 -5.5% 38 7.89
48Z
197.05 78.8B 47.44 15.49 33.73 21.3% 10.4% 43 42 89.00 -41.1% 76 0.81
PTX
174.78 420.0B 100.00 48.39 176.94 32.7% 10.8% 42 37 43.70 -56.2% 99 0.02
SYP
412.00 78.8B 78.78 2.85 25.69 2.2% 10.1% 41 25 259.56 -26.6% 70 0.35
AMD
492.35 803.5B 100.00 13.39 83.91 8.9% 10.7% 40 25 126.08 -55.8% 95 0.06
CDS
293.55 80.8B 66.07 13.27 40.52 16.7% 10.6% 40 35 113.10 -46.1% 90 0.39
GLW
121.30 104.3B 61.80 9.35 29.60 12.6% 10.2% 40 32 56.87 -39.8% 75 0.75
CIE1
313.90 44.5B 51.75 16.41 52.48 19.1% 10.7% 39 39 105.22 -49.9% 80 1.07
NOA3
8.33 46.6B 65.87 2.20 22.48 2.0% 10.3% 39 26 5.45 -24.9% 81 0.16
1ZB
205.50 60.3B 100.00 41.90 193.50 19.8% 10.4% 37 32 51.38 -56.2% 66 1.74
KLA
153.30 2,003.6B 100.00 358.44 362.89 46.6% 10.8% 37 37 38.33 -56.2% 81 0.97
4S0
128.65 133.0B 89.69 11.97 44.49 6.5% 10.4% 34 28 51.85 -44.8% 66 0.68
XPH
73.03 360.1B 78.75 29.01 52.81 15.4% 10.4% 33 32 23.14 -51.2% 72 1.34
9MW
218.55 196.4B 100.00 11.93 46.75 6.7% 10.7% 32 23 69.54 -51.1% 88 0.29
INL
84.93 428.3B — 5.56 142.60 2.2% 9.9% 25 26 25.91 -44.5% 50 0.58
5AP
312.40 254.6B — 10.53 208.08 1.6% 10.7% 23 15 83.28 -50.6% 69 0.09

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.